Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07681141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies

Name: Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies — clinical trial record (NCT07681141)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2025-04-01

View on ClinicalTrials.gov ↗

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

This first-in-human study aimed to assess the safety and internal radiation dosimetry of 177Lu-JH040182, a novel FAP-targeted radiopharmaceutical, in patients with FAP-positive tumors. All patients underwent screening via 68Ga-FAPI PET/CT. Those confirmed to have FAP-positive lesions on PET imaging received administration of 177Lu-JH040182, and serial-time-point SPECT images were acquired for internal radiation dosimetry calculations.

Trial Details

NCT Number	NCT07681141
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Patients With Advanced Metastatic FAP-Positive Tumors
Enrollment	3 participants
Start Date	2025-04-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-02